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Abstract
Background: Nerve growth factor (NGF) helps in the healing and survival of ganglion cells,
photoreceptors, and optic nerve after injury and has been implicated to have a role in
pathophysiology of glaucoma. So far, in animal studies, injury to iris in vitro has revealed an increase
in NGF levels in aqueous. There is a great interest in investigating the levels of NGF in human
aqueous in glaucomatous eyes, as suggested by animal studies, to gain a better understanding of the
pathophysiology of glaucoma.
Findings: In this study, we examined the presence of NGF levels in aqueous humor collected from
human eyes and the limitations in determining the NGF levels in human samples. NGF was assessed
by ELISA immunoassay in undiluted aqueous samples collected from 32 consecutive patients
undergoing surgery for cataract (control) or primary open angle glaucoma (POAG). Recombinant
NGF was used as positive control. NGF levels were below undetectable levels in aqueous humor
from eyes with POAG and controls by immunoassay. Less than 10% of samples had detectable NGF
levels and these were considered outliers.
Conclusion: Our result highlights the undetectable levels of NGF in human aqueous samples.
Introduction
Aqueous occupies the anterior and posterior chambers of
the eye and nourishes the lens and the corneal endothe-
lium. The aqueous composition resembles that of plasma,
but contains much less proteins and glucose. It has higher
levels of lactic and ascorbic acids. A number of studies
have implicated nerve growth factor (NGF) in pathophys-
iology of glaucoma [1-3]. NGF receptors have been dem-
onstrated on human trabecular meshwork [2,4] make it
interesting to investigate changes in NGF levels in aque-
ous samples from patients. In this study we evaluated the
feasibility of measuring NGF levels in aqueous samples
using a commonly used ELISA kit.
Methods
The study was approved by the Institutional Review
Board, University of Florida, Jacksonville. An informed
consent was obtained from all the patients included in the
study. Aqueous samples were collected from 32 consecu-
tive patients undergoing surgery for cataract (control) or
primary open angle glaucoma (POAG). At the time of sur-
gery, after preparing the eye, undiluted aqueous sample
was collected from the anterior chamber by a 27 gauge
insulin syringe. Samples were immediately frozen at -
80°C and thawed immediately before assay. 18 patients
had POAG and 14 patients had cataract.
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Most frequent sample size that could practically be col-
lected (mode) was 50 μL of aqueous. ELISA immunoassay
was performed to quantify the NGF levels in the aqueous
(Promega, Madison, WI). In this kit, flat-bottom 96-well
plates are coated with Anti-NGF Polyclonal Antibody
which binds soluble NGF. The plates are covered and
incubated overnight at 4°C. The following day the plates
are washed and blocking buffer added in the wells.
Human beta-NGF (PeproTech, Rocky Hill, NJ) was used
as external positive control (in addition to NGF provided
by the kit for standard curve) and buffer as negative con-
trol. Due to limitation of the sample size, 50 μL of undi-
luted samples were used to run the assay. All samples
could be run in single, except the standards and controls.
Most samples were in the range of 50 μL, therefore this
quantity was used as a standard sample size. Some sam-
ples had smaller quantity (40 μL) where this sample was
diluted to make 50 μl and eventually dilution factor was
accounted for in the final calculations. Following six
hours of incubation with shaking at room temperature,
the plate was washed and secondary antibody (anti NGF
mAb) was added. Plate was incubated overnight without
shaking at 4°C. Next day, plate was washed and Anti-Rat
IgG, HRP conjugate was added. Following 2.5 hours of
incubation at room temperature and wash, TMB solution
was added. Reaction was stopped with 1N hydrochloric
acid and the plate read at A450 within 30 minutes.
Results
In the POAG samples (n = 18) the mean age of the sub-
jects was 74.2 yrs and in controls (n = 14) the mean age of
the subjects was 69 years.
With undiluted samples, the typical average levels of NGF
were 0.91 pg/ml (standard error 0.52) in aqueous samples
of patients with POAG and 0.82 pg/ml (standard error
0.47) in aqueous samples of controls. Levels were consid-
ered undetectable as these were below the detection sensi-
tivity of the kit (7.8 pg/ml). In each experiment external
recombinant NGF controls were kept and their values
(coefficient of determination; R2 = 1) were detected as pre-
dicted (Fig. 1). However, in both glaucoma and control
groups approximately 5.5% and 7.1% of samples had
NGF values as high as 75.3 pg/ml and 17.9 pg/ml respec-
tively.
Even in pilot experiments quantities ranging from 15 to
50 μl and dilutions ranging from 1:1.25–3.3 were used
but NGF levels were found to be undetectable and on rare
occasions when larger quantities were available (up to
100 μL; n = 2) the NGF levels were still undetectable.
Discussion
Results show that the NGF was present in aqueous humor
in a concentration below 1 pg/ml. These levels are below
the sensitivity limit of the kit used, thus they were consid-
ered undetectable. However, since the standard curve as
well as external positive control values were linear below
the 7.8 pg/ml sensitivity levels, it is possible that the
detected levels represent actual NGF values. The results
from aqueous samples are considered reliable because the
positive controls give predictable values. Quantity of sam-
ple size available from patients posed a problem; how-
ever, even when 100 μL of aqueous was available the NGF
levels were undetectable. The same experiment was per-
A) Standard curve as well as external positive control values  were linear below the 10 pg/ml NGF levels, comparable to  7.8 pg/ml sensitivity level of the Elisa kit Figure 1
A) Standard curve as well as external positive control values 
were linear below the 10 pg/ml NGF levels, comparable to 
7.8 pg/ml sensitivity level of the Elisa kit. B) ELISA on the 
aqueous samples from patients' undergone cataract and 
POAG surgery. Standard curve has a R2 value of 1 and the 
recombinant NGF kept as positive control show predicted 
values (R2 = 1). In both control (green diamond) and POAG 
(red triangles) samples NGF was below the sensitivity of the 
kit.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Research Notes 2008, 1:22 http://www.biomedcentral.com/1756-0500/1/22
Page 3 of 3
(page number not for citation purposes)
formed two more times with additional samples and the
results were comparable. This is consistent with low quan-
tities of proteins present in aqueous [5].
Several methods have been described in the literature to
enhance detectability of a protein [6]. Even in the pres-
ence of low levels of starting proteins, sample dilutions,
possibly by diluting other interfering proteins, can some
times improve detectability. However, even with dilution
in pilot studies NGF levels in aqueous remained below
sensitivity levels. Methods have been described to extract
NGF in samples by acidification. This method requires
acid treatment and readjustment of the pH [7]. Pretreat-
ment or pH shock extraction was not feasible because of
the small sample size. Other possibility is to concentrate
the sample with freeze-dry method. This method could
only be used if we pooled the samples from different
patients. This will however preclude our aim of detecting
NGF levels in individual subjects.
The samples with higher values were considered outliers
(with respect to patient groups of control and POAG)
because (1) these values were rare and highly inconsistent
with others in the group (2) they were found with equal
frequency in control and glaucomatous eyes. Histories of
outliers were reviewed to identify any apparent cause but
none was identified.
Our results highlight the difficulties in assessing NGF lev-
els in aqueous. An alternate strategy could be to pool the
samples from different patients (but from same group) in
order to increase the sample volume and therefore the
detectability. However, results also show that outliers may
skew the results obtained by pooling the samples. The
outliers may be a result of variables at the time of collec-
tion of sample (e.g. per operative trauma, bleeding, iris
handling etc). There are reports in the literature where
NGF levels have been assessed in animals [3,8] and in
humans [1].
Our result highlights the limitations in collection of 100
μl of human aqueous sample for Elisa assay, to determine
the nerve growth factor levels. This result differs from lim-
ited reports where NGF levels have been reported in aque-
ous samples [1,3,8]. However, in these reports
methodological details are not clear if 100 microlitres of
aqueous was obtained by pooling the samples. Consider-
ing these limitations, other technologies such as multiplex
assays might be more useful.
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